CVVH在致死性苯巴比妥超剂量清除中的有效作用:一例报告

Ebad Chaudhry Adeel, G. Alan, J ConlonPeter
{"title":"CVVH在致死性苯巴比妥超剂量清除中的有效作用:一例报告","authors":"Ebad Chaudhry Adeel, G. Alan, J ConlonPeter","doi":"10.23937/2572-3286.1510034","DOIUrl":null,"url":null,"abstract":"We report affective utilization of continuous veno-venous hemofiltration for removal of phenobarbital in a patient who took twice amount of fatal dose and was hemodynamically stable. Historically treatment includes supportive care, activated charcoal and urinary alkalinisation along with the application of extracorporeal treatments such as charcoal haem perfusion or hemodialysis and continuous veno-venous hemodiafiltration are affective treatment for removal of drug. Early initiation of extracorporeal treatment and increasing blood flow rate effectively reduced half life of drug and improved patient outcome with fatal poisoning. known time. He was brought unconscious had GCS of 3 blood pressure 120/75 pulse 85 per minutes’ respiratory rate 12 per minutes’ and temperature of 36.5 °C was intubated and ventilated and transferred to intensive care unit. His medical background history includes bipolar disorder, deliberate self harm. His initial investigation showed positive blood and urine toxicology screen for barbiturates only and phenobarbital level of 160.5 mg/L, others investigation including full blood count, renal profile, liver function, arterial blood gases, calcium, phosphate, amylase, creatinine kinase and coagulation screen within normal limits (Table 1). His electrocardiogram showed prolonged QT. He remained hemodynamically stable without any inotropic support was started on supportive management with intravenous fluid and activated charcoal in intensive care unit as renal profile and acid base status remained within fair range with no evidence of renal failure. His repeat phenobarbital level after 48 hours was 221.8 mg/L likely due to redistribution of drug.","PeriodicalId":73669,"journal":{"name":"Journal of clinical nephrology and renal care","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effective Role of CVVH in Fatal Phenobarbital Overdose Clearance: A Case Report\",\"authors\":\"Ebad Chaudhry Adeel, G. Alan, J ConlonPeter\",\"doi\":\"10.23937/2572-3286.1510034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We report affective utilization of continuous veno-venous hemofiltration for removal of phenobarbital in a patient who took twice amount of fatal dose and was hemodynamically stable. Historically treatment includes supportive care, activated charcoal and urinary alkalinisation along with the application of extracorporeal treatments such as charcoal haem perfusion or hemodialysis and continuous veno-venous hemodiafiltration are affective treatment for removal of drug. Early initiation of extracorporeal treatment and increasing blood flow rate effectively reduced half life of drug and improved patient outcome with fatal poisoning. known time. He was brought unconscious had GCS of 3 blood pressure 120/75 pulse 85 per minutes’ respiratory rate 12 per minutes’ and temperature of 36.5 °C was intubated and ventilated and transferred to intensive care unit. His medical background history includes bipolar disorder, deliberate self harm. His initial investigation showed positive blood and urine toxicology screen for barbiturates only and phenobarbital level of 160.5 mg/L, others investigation including full blood count, renal profile, liver function, arterial blood gases, calcium, phosphate, amylase, creatinine kinase and coagulation screen within normal limits (Table 1). His electrocardiogram showed prolonged QT. He remained hemodynamically stable without any inotropic support was started on supportive management with intravenous fluid and activated charcoal in intensive care unit as renal profile and acid base status remained within fair range with no evidence of renal failure. His repeat phenobarbital level after 48 hours was 221.8 mg/L likely due to redistribution of drug.\",\"PeriodicalId\":73669,\"journal\":{\"name\":\"Journal of clinical nephrology and renal care\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical nephrology and renal care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23937/2572-3286.1510034\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical nephrology and renal care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2572-3286.1510034","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

我们报告持续静脉-静脉血液滤过去除苯巴比妥的有效利用在病人服用两倍的致死剂量和血液动力学稳定。历史上的治疗包括支持治疗,活性炭和尿碱化以及体外治疗的应用,如木炭血红素灌注或血液透析和持续的静脉-静脉血液透析滤过是去除药物的有效治疗。尽早开始体外治疗和增加血流量可有效缩短药物半衰期,改善致死性中毒患者的预后。已知的时间。患者昏迷,GCS 3,血压120/75,脉搏85 /分钟,呼吸频率12 /分钟,体温36.5°C,插管通气,转重症监护病房。他的病史包括躁郁症,故意自残。他的初步调查显示血液和尿液毒理学筛查阳性,仅巴比妥类药物和苯巴比妥水平为160.5 mg/L,其他调查包括全血细胞计数、肾谱、肝功能、动脉血气、钙、磷酸盐、淀粉酶、他的心电图显示QT间期延长,在没有任何肌力支持的情况下,他的血流动力学保持稳定,在重症监护病房开始静脉输液和活性炭的支持管理,因为肾脏特征和酸碱状态保持在合理范围内,没有肾衰竭的迹象。48小时后重复苯巴比妥水平为221.8 mg/L,可能与药物重新分配有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effective Role of CVVH in Fatal Phenobarbital Overdose Clearance: A Case Report
We report affective utilization of continuous veno-venous hemofiltration for removal of phenobarbital in a patient who took twice amount of fatal dose and was hemodynamically stable. Historically treatment includes supportive care, activated charcoal and urinary alkalinisation along with the application of extracorporeal treatments such as charcoal haem perfusion or hemodialysis and continuous veno-venous hemodiafiltration are affective treatment for removal of drug. Early initiation of extracorporeal treatment and increasing blood flow rate effectively reduced half life of drug and improved patient outcome with fatal poisoning. known time. He was brought unconscious had GCS of 3 blood pressure 120/75 pulse 85 per minutes’ respiratory rate 12 per minutes’ and temperature of 36.5 °C was intubated and ventilated and transferred to intensive care unit. His medical background history includes bipolar disorder, deliberate self harm. His initial investigation showed positive blood and urine toxicology screen for barbiturates only and phenobarbital level of 160.5 mg/L, others investigation including full blood count, renal profile, liver function, arterial blood gases, calcium, phosphate, amylase, creatinine kinase and coagulation screen within normal limits (Table 1). His electrocardiogram showed prolonged QT. He remained hemodynamically stable without any inotropic support was started on supportive management with intravenous fluid and activated charcoal in intensive care unit as renal profile and acid base status remained within fair range with no evidence of renal failure. His repeat phenobarbital level after 48 hours was 221.8 mg/L likely due to redistribution of drug.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信